首页 > 市场调查报告书 > 製药

以基因为基之药物开发

市场调查报告书

商品编码

1547568

全球蛋白质体学市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Proteomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球蛋白质体学市场需求预计将从 2023 年的 362 亿美元达到近 1,179.2 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 14.02%。

蛋白质体学研究生物系统内蛋白质的结构、功能和相互作用。它涉及对蛋白质的大规模分析，包括其表达水平、翻译后修饰和蛋白质-蛋白质相互作用，以了解它们在细胞过程、疾病机制和生物途径中的作用。它采用质谱、蛋白质分离和生物资讯技术来识别、量化和表征复杂生物样品中的蛋白质。它对于提高我们在分子生物学、生物标记发现、药物开发和个人化医疗方面的知识至关重要，并为疾病诊断、预后和治疗提供见解。

市场动态

在质谱技术进步的推动下，蛋白质体学市场正在经历显着成长，而生物资讯学正在彻底改变该领域，使蛋白质分析变得更加精确和全面。这项技术进步使蛋白质体学变得更加容易获得和高效，从而推动了其在各种研究和临床应用中的采用。此外，癌症和心血管疾病等慢性疾病的流行，推动了对基于蛋白质组学的诊断和治疗的需求，因为了解蛋白质功能和相互作用对于疾病发病机制和治疗至关重要。政府和私营部门对研究的投资也提振了市场，为创新项目和开发提供必要的资金。对个人化医疗日益增长的兴趣进一步推动了市场的发展，因为蛋白质体分析在根据患者独特的蛋白质谱定制治疗方案方面发挥关键作用。学术机构和生物技术公司之间的合作正在促进进步，加上对生物标记发现和药物开发的日益关注，共同推动了市场的成长，使其成为现代生物医学研究和医疗保健的关键领域。然而，道德问题和监管障碍可能会阻碍未来几年市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球蛋白质体学市场的每个细分市场进行了包容性评估。蛋白质体学产业的成长和趋势为这项研究提供了整体方法。

市场区隔

蛋白质体市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按产品范围

仪器仪表
试剂及耗材
服务

按应用范围

药物发现
临床诊断
其他的

按技术范围

微阵列仪器
X射线晶体学
光谱学
色谱法
蛋白质分级分离系统
电泳
表面等离子体共振 (SPR) 系统

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲蛋白质体学市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。蛋白质体学市场的主要参与者包括Illumina Inc.、Agilent Technologies Inc.、Bio-Rad Laboratories Inc.、GE Healthcare、Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd.、Promega Corp.、Merck KGaA、 Danaher 。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：蛋白质体学公司的竞争格局

蛋白质体学市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Illumina Inc.

公司概况
公司收入
产品
最新动态

Agilent Technologies Inc.

公司概况
公司收入
产品
最新动态

Bio-Rad Laboratories Inc.

公司概况
公司收入
产品
最新动态

GE Healthcare

公司概况
公司收入
产品
最新动态

Thermo Fisher Scientific Inc.

公司概况
公司收入
产品
最新动态

F. Hoffmann-La Roche Ltd.

公司概况
公司收入
产品
最新动态

Promega Corp.

公司概况
公司收入
产品
最新动态

Merck KGaA

公司概况
公司收入
产品
最新动态

Danaher

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11214795

The global demand for Proteomics Market is presumed to reach the market size of nearly USD 117.92 Billion by 2032 from USD 36.2 Billion in 2023 with a CAGR of 14.02% under the study period 2024-2032.

Proteomics studies proteins' structure, function, and interactions within a biological system. It involves the large-scale analysis of proteins, including their expression levels, post-translational modifications, and protein-protein interactions, to understand their roles in cellular processes, disease mechanisms, and biological pathways. It employs mass spectrometry, protein separation, and bioinformatics techniques to identify, quantify, and characterize proteins in complex biological samples. It is crucial in advancing our knowledge of molecular biology, biomarker discovery, drug development, and personalized medicine, offering insights into disease diagnosis, prognosis, and treatment.

MARKET DYNAMICS

The proteomics market is experiencing significant growth driven by advances in mass spectrometry, and bioinformatics are revolutionizing the field, enabling more precise and comprehensive analysis of proteins. This technological progress makes proteomics more accessible and efficient, thus fuelling its adoption in various research and clinical applications. Additionally, the spurring prevalence of chronic diseases, such as cancer & cardiovascular disorders, is driving the demand for proteomics-based diagnostics and therapeutics, as understanding protein functions and interactions is crucial for disease pathogenesis and treatment. Government and private sector investments in research are also bolstering the market, providing necessary funding for innovative projects and developments. The growing interest in personalized medicine further propels the market, as proteomic analysis plays a critical role in tailoring treatments to individual patients based on their unique protein profiles. Collaborations between academic institutions and biotechnology companies are fostering advancements, coupled with the increasing focus on biomarker discovery and drug development, collectively driving the market's growth, making it a pivotal area in modern biomedical research and healthcare. However, ethical concerns and regulatory hurdles may hinder the market's growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Proteomics. The growth and trends of Proteomics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Proteomics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Scope

Instruments
Reagents & Consumables
Services

By Application Scope

Drug Discovery
Clinical Diagnostics
Others

By Technology Scope

Microarray Instruments
X-Ray Crystallography
Spectroscopy
Chromatography
Protein Fractionation Systems
Electrophoresis
Surface Plasma Resonance (SPR) Systems

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Proteomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Proteomics market include Illumina Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Promega Corp., Merck KGaA, Danaher. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PROTEOMICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Scope
- 3.7.2 Market Attractiveness Analysis By Application Scope
- 3.7.3 Market Attractiveness Analysis By Technology Scope
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PROTEOMICS MARKET ANALYSIS BY PRODUCT SCOPE

5.1. Overview By Product Scope
5.2. Historical and Forecast Data Analysis By Product Scope
5.3. Instruments Historic and Forecast Sales By Regions
5.4. Reagents & Consumables Historic and Forecast Sales By Regions
5.5. Services Historic and Forecast Sales By Regions

6. GLOBAL PROTEOMICS MARKET ANALYSIS BY APPLICATION SCOPE

6.1. Overview By Application Scope
6.2. Historical and Forecast Data Analysis By Application Scope
6.3. Drug Discovery Historic and Forecast Sales By Regions
6.4. Clinical Diagnostics Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL PROTEOMICS MARKET ANALYSIS BY TECHNOLOGY SCOPE

7.1. Overview By Technology Scope
7.2. Historical and Forecast Data Analysis By Technology Scope
7.3. Microarray Instruments Historic and Forecast Sales By Regions
7.4. X-Ray Crystallography Historic and Forecast Sales By Regions
7.5. Spectroscopy Historic and Forecast Sales By Regions
7.6. Chromatography Historic and Forecast Sales By Regions
7.7. Protein Fractionation Systems Historic and Forecast Sales By Regions
7.8. Electrophoresis Historic and Forecast Sales By Regions
7.9. Surface Plasma Resonance (SPR) Systems Historic and Forecast Sales By Regions

8. GLOBAL PROTEOMICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PROTEOMICS COMPANIES

9.1. Proteomics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF PROTEOMICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Illumina Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Agilent Technologies Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Bio-Rad Laboratories Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. GE Healthcare
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Thermo Fisher Scientific Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. F. Hoffmann-La Roche Ltd.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Promega Corp.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Merck KGaA
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Danaher
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments